💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Neurocrine Biosciences, Inc. (NBIX)
« Back to company indexNBIX Chatter Timeline
Stock Ticker for NBIX
Most Active Tweeters for NBIX
| User | Tweets |
|---|---|
| @SmartTradeUSA | 7 |
| @FlashAlert_me | 5 |
| @Gambiste1 | 4 |
| @ChartMill | 3 |
| @portefeuillefun | 3 |
Recent Tweets for NBIX
 |
@ChartMill $NBIX was analyzed by 19 analysts. The buy consensus is at 88%. So analysts seem to be very confident about $NBIX.… https://t.co/RFMWJLz00J 4:01am |
 |
@brettchandler $EBS & $NBIX 2x rare ??biotech?? #stonks that actually have the creds to make @PatternProfits stringent FL, very si… https://t.co/n7z0HN9lGA January 17th 2021, 6:01am |
|
@ChartMill $NBIX was analyzed by 19 analysts. The buy consensus is at 88%. So analysts seem to be very confident about $NBIX.… https://t.co/qUAq2p8fNq January 17th 2021, 2:01am |
 |
@portefeuillefun Bought 2.1k $NBIX at $107.69, now 2.5k #vssporte shares. January 16th 2021, 10:01am |
|
@portefeuillefun $NBIX $ABBV. https://t.co/khqjC1zw9N January 16th 2021, 10:01am |
 |
@Anton_A9 $NBIX - went above 200 ma today, now checking back and working off overbought, looking for continuation next week. https://t.co/D48LKlNO32 January 16th 2021, 12:01am |
 |
@Trefis Neurocrine, Ionis, Vertex: Underperforming Healthcare Stocks Poised To Recover: https://t.co/fb9ni7XQmM $NBIX… https://t.co/bx0fP86YER January 15th 2021, 4:01pm |
 |
@mediasentiment $NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 47 January 15th 2021, 9:01am |
 |
@Gambiste1 RT @JamesEKrause: I followed $CARA/CEO Derek Chalmers since $NBIX days way back. Novel anti-itch drug, unmet need. Cara filed NDA for IV #K… January 15th 2021, 5:01am |
 |
@JamesEKrause I followed $CARA/CEO Derek Chalmers since $NBIX days way back. Novel anti-itch drug, unmet need. Cara filed NDA for… https://t.co/81AuAqoKsj January 15th 2021, 3:01am |
 |
@TomSilver39 Cantor:" $NBIX continue to see robust INGREZZA sales in TD, with preliminary 4Q20 INGREZZA revenues reported on Jan… https://t.co/YrHIgNHGcx January 14th 2021, 6:01pm |
|
@mediasentiment $NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 53 January 14th 2021, 9:01am |
 |
@BioWino they couldn't get enough of $nbix.. today.. flash crash January 13th 2021, 4:01pm |
|
@Gambiste1 RT @PMDiChristina: If at first you don’t succeed $NBIX https://t.co/zR0p3GBL8C January 13th 2021, 4:01am |
 |
@PMDiChristina If at first you don’t succeed $NBIX https://t.co/zR0p3GBL8C January 13th 2021, 2:01am |
 |
@InsiderAlerts4U $NBIX: New Insider Filing on NEUROCRINE BIOSCIENCES INC's Chief Executive Officer KEVIN CHARLES GORMAN: https://t.co/77shzmEvkA January 12th 2021, 9:01pm |
|
@InsiderAlerts4U $NBIX: New Insider Filing on NEUROCRINE BIOSCIENCES INC's Chief Medical Officer EIRY ROBERTS: https://t.co/GsfPagsD9H January 12th 2021, 9:01pm |
 |
@fintel_io Insider Eiry Roberts reports selling 2,632 shares of $NBIX for a total cost of $292,297.29 https://t.co/JQoijrNq5z January 12th 2021, 9:01pm |
 |
@FlashAlert_me $NBIX [15s. delayed] filed SEC form 4: Chief Medical Officer ROBERTS EIRY: Disposed 2,632 of Common Stock at price… https://t.co/Io24P49CLi January 12th 2021, 9:01pm |
 |
@formwhisperscom #FWSells $NBIX ROBERTS EIRY, Chief Medical Officer of NEUROCRINE BIOSCIENCES INC sold 2,632 shares on 2021-01-08. https://t.co/qiBNPGIp14 January 12th 2021, 9:01pm |
 |
@insiderbuyings $NBIX new insider selling: 308250 shares. https://t.co/7DopyDlcdD January 12th 2021, 9:01pm |
|
@FlashAlert_me $NBIX [15s. delayed] filed SEC form 4: Chief Executive Officer GORMAN KEVIN CHARLES: Disposed 308,250 of Common St… https://t.co/xlQEkRa6zX January 12th 2021, 9:01pm |
|
@formwhisperscom #FWSells $NBIX GORMAN KEVIN CHARLES, Chief Executive Officer of NEUROCRINE BIOSCIENCES INC sold 308,250 shares on 2… https://t.co/mCS91nCh7e January 12th 2021, 9:01pm |
|
@fintel_io Insider Kevin Charles Gorman reports selling 308,250 shares of $NBIX for a total cost of $33,973,876.51 https://t.co/X6cSl3U0Zo January 12th 2021, 9:01pm |
 |
@YuZhu4 RT @semodough: $NBIX phase 3 top-line data for valbenazine in chorea in Huntington Disease are expected in 4Q21 (on track; sNDA planned for… January 12th 2021, 7:01pm |
 |
@semodough $NBIX phase 3 top-line data for valbenazine in chorea in Huntington Disease are expected in 4Q21 (on track; sNDA pl… https://t.co/CUaQr29lKK January 12th 2021, 7:01pm |
 |
@TradeWithAlerts Large Print $NBIX Size: 128200 Price: 111.265 Time: 1422 Amount: $14,264,173.00 January 11th 2021, 7:01pm |
|
@TradeWithAlerts Large Print $NBIX Size: 183829 Price: 109.84 Time: 1127 Amount: $20,191,777.36 January 11th 2021, 4:01pm |
|
@Gambiste1 RT @The_General75: $NBIX Check out this chart I made with @TrendSpider https://t.co/au2fCpNfXg January 11th 2021, 2:01am |
 |
@The_General75 $NBIX Check out this chart I made with @TrendSpider https://t.co/au2fCpNfXg January 11th 2021, 2:01am |
 |
@MarketChmln $NBIX upcoming event January 11: 39th Annual J.P. Morgan Healthcare Conference. Options expiring on January 15 that… https://t.co/4VfGHbfNsw January 11th 2021, 1:01am |
 |
@wh3atth1nz $NBIX showing some signs of big buying off the lows and now starting to build out possible right side of this base.… https://t.co/SIFADOzsQm January 10th 2021, 5:01pm |
 |
@FinoGinofino $NBIX #NBIX daily 8 Jan. 20 https://t.co/UqHSfwNlb3 January 10th 2021, 12:01pm |
 |
@lblegend33 $nbix $112 now https://t.co/x2m7Luuq31 January 8th 2021, 1:01pm |
|
@portefeuillefun Sold 0.2k $NBIX at $110.39, now 0.4k #vssporte shares. January 8th 2021, 12:01pm |
 |
@QuantchaIdeas Big Gainer Alert: Trading today’s 7.4% move in NEUROCRINE BIOSCIENCES $NBIX https://t.co/hEPSR0yPQ4 January 8th 2021, 11:01am |
 |
@MarcJacksonLA $NBIX Neurocrine Biosciences Provides Preliminary 4th Quarter & Full Year 2020 Results & 2021 Program Milestones https://t.co/y1o80cILGC January 8th 2021, 11:01am |
 |
@SmartTradeUSA $NBIX ? https://t.co/Z6HQ9Q6kos January 8th 2021, 9:01am |
|
@SmartTradeUSA $NBIX ? https://t.co/qECHevWmPe January 8th 2021, 9:01am |
 |
@ResearchPool $NBIX #Neurocrine Biosciences Inc. 4Q20 Pre-Announcement - Ingrezza Miss, But Largely Anticipated: [...]… https://t.co/cHROiNJTkv January 8th 2021, 8:01am |
 |
@Beeken_health $NBIX - Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and… https://t.co/2JVY9MxWCB January 8th 2021, 8:01am |
 |
@newsfilterio Neurocrine Bio sees Ingrezza sales of $993M in FY20 $NBIX https://t.co/DrsWOHd0WD January 8th 2021, 8:01am |
 |
@StckPro $NBIX NEW ARTICLE : Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales… https://t.co/MNOTPVH32c January 8th 2021, 7:01am |
 |
@MarketCurrents $NBIX - Neurocrine Bio sees Ingrezza sales of $993M in FY20 https://t.co/jHBSWAYjoE January 8th 2021, 7:01am |
 |
@Sanctuary_Bio RT @bio_clouseau: $NBIX 4Q net sales of 240M (adjusted 258M) for valbenazine continuing Q/Q reduction in sales https://t.co/EUvrzZoBFv January 8th 2021, 7:01am |
 |
@sbwcws Neurocrine plans to initiate seven mid-to-late stage clinical studies in 2021 $NBIX January 8th 2021, 7:01am |
 |
@TheStockWire $NBIX Neurocrine: Expects INGREZZA Net Pdt Sales for the Three Mos and full-Yr Ended Dec 31 to Be Approximately $24… https://t.co/kQg6fxhU96 January 8th 2021, 7:01am |
 |
@bio_clouseau $NBIX 4Q net sales of 240M (adjusted 258M) for valbenazine continuing Q/Q reduction in sales https://t.co/EUvrzZoBFv January 8th 2021, 7:01am |
 |
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0RQ8WtsgbR January 8th 2021, 7:01am |
|
@sbwcws Neurocrine sees Q4 INGREZZA net product sales approximately $240M $NBIX January 8th 2021, 7:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
